Alternative antibody for the detection of CA19-9 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access® GI Monitor assay on the UniCel® DxI 800 Immunoassay System
Lists
Only you see this
Abstract
The Access GI Monitor provides very good methodological characteristics and demonstrates an excellent analytical and clinical correlation with the Elecsys CA19-9. The GI Monitor shows the best diagnostic accuracy in pancreatic cancer. Our results also suggest a clinical value of the GI Monitor in other cancers.
BibTeX
@inproceedings{stieber2008alternative,
author = {P Stieber and Rafael Molina and Massimo Gion and Axel M. Gressner and Frédéric Troalen and Stefan Holdenrieder and José Maria Augé and Matelda Zancan and Matthias Wycislo and Véronique Jarrige},
title = {{Alternative antibody for the detection of CA19-9 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access® GI Monitor assay on the UniCel® DxI 800 Immunoassay System}},
booktitle = {Clinical},
year = {2008},
doi = {10.1515/cclm.2008.126},
}